emtricitabine; tenofovir disoproxil

Generic: EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE·Brand: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, TRUVADA

emtricitabine; tenofovir disoproxil: 2 clinical trials tracked.

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.

BioSniper AIPage evidence connected

Prepared research question

What is verified about emtricitabine; tenofovir disoproxil, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (2)

PrEPsmart Pilot: a Trial to Evaluate a Mobile App to Support the Safe and Effective Use of On-demand Pre-exposure Prophylaxis (PrEP) Among Sexual Minority Men in the US

NCT06631365Registry updated 2024-10-08·Phase 2

Recruiting

Primary endpoint: Acceptability of the PrEPsmart mobile app

InterventionalRandomizedopen60 targetStarted 2023-10Completion 2025-041 site · United StatesPublic Health Foundation Enterprises, Inc.

A Phase 2a Crossover Trial Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population

NCT03074786Registry updated 2017-09-08·Phase 2

Withdrawn

Primary endpoint: Safety assessed by grade 2 or higher adverse event.

InterventionalRandomizedopen0 targetStarted 2017-11Completion 2020-121 site · South AfricaInternational Partnership for Microbicides, Inc.

emtricitabine; tenofovir disoproxil evidence translation